Advertisement

Systemkrankheiten mit Beteiligung des Respirationstraktes

  • E. Weissbarth-Riedel
  • C. Rieger
  • K. Paul
  • N. Teig
  • H. von der Hardt
  • V. Stephan

Zusammenfassung

Rheumatische Erkrankungen können verschiedene anatomische Strukturen der Atemwege und der Lunge betreffen. Am bekanntesten ist die Pleuritis bei Morbus Still, der systemischen Form der juvenilen chronischen Arthritis, oder als Symptom des Lupus erythematodes. Rheumatische Krankheiten können aber auch das Lungengewebe als interstitielle Pneumonitis mit der möglichen Folge einer Lungenfibrose betreffen. Obstruktive Ventilationsstörungen finden sich als Folge einer subglottischen Stenose oder Bronchusstenose bei der Wegener-Granulomatose. Bei der Dermatomyositis kann es durch die Schwäche der Atemmuskulatur bis zur respiratorischen Insuffizienz kommen. Eine mangelnde Dehnbarkeit der Thoraxwand kann bei der Sklerodermie zu einer restriktiven Ventilationsstörung führen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Cassidy JT, Petty RE (1995) Textbook of Pediatric Rheumatology, 3rd edn.Google Scholar
  2. Cottin V, Tebib J, Massonet B, Sonquet PJ, Bernard JP (1996) Pulmonary function in patients receiving long-term low dose methotrexate. Chest 109 (4): 933–939PubMedCrossRefGoogle Scholar
  3. De Kleer JM, Knook LME, Van der Ent K, Van der Net JJ, Prakken BJ, Knis W (1997) Lungfunction abnormalities in JCA are caused by a pronounced impairment in respiratory muscle strength and result in an increase of the patient’s disability. Rev Rheum [Engl edn] 64 (10, Suppl): 218 sGoogle Scholar
  4. Delgado EA, Malleson PN, Pixie GE, Petty RE (1990) The pulmonary manifestations of childhood onset systemic lupus erythematosus. Semin Arthritis Rheum 19 (5): 285–293PubMedCrossRefGoogle Scholar
  5. Michels H (1996) Outcome of children with mixed connective tissue disease. IV European Conference of Pediatric Rheumatology. Clin Exp Rheumatol 14: 452Google Scholar
  6. Murray JF, Nadel JA (1994) Textbook of respiratory medicine, 2nd edn. Saunders, PhiladelphiaGoogle Scholar
  7. Pachman LM (1994) Juvenile dermatomyositis (JDMS): new clues to diagnosis and pathogenesis. Clin Exp Rheumatol 12 (Suppl 10): S69 - S73Google Scholar
  8. Pelucchi A, Lomater C, Gerloni V, Foresi A, Fantini F, Marazzini L (1994) Lungfunction and diffusing capacity for carbon monoxide in patients with juvenile chronic arthritis: effect of disease activity and low dose methotrexate therapy. Clin Exp Rheumatol 12: 675–679PubMedGoogle Scholar
  9. Ravelli A, Viola S, Ballardini G, Greco AM, Saggese T, Zuliani J, Martini A (1995) Methotrexate pneumonitis in juvenile chronic arthritis. Clin Exp Rheumatol 13: 561Google Scholar
  10. Rottem M, Fauci AS, Hallahan CW, Kerra GS, Lebovics RY, Hoffman GS (1993) Wegener granulomatosis in children and adolescents: Clinical presentation and outcome. J Pediatr 122: 26–31Google Scholar
  11. Agostini C, Trentin L, Facco M et al. (1996) Role of IL-15, IL-2 and their receptors in the development of T-cell alveolitis in pulmonary sarcoidosis. J Immunol 157: 910PubMedGoogle Scholar
  12. Büscher R, Schaper J, Müller KM, Ratjen F (1997) Pulmonary manifestation of sarcoidosis in early childhood. Monatsschr Kinderheilkd 145: 802–805CrossRefGoogle Scholar
  13. Chadelat K, Baculard A, Grimfeld A, Tournier G, Boule M, Boccon-Gibod L, Clement A (1993) Pulmonary sarcoidosis in children: serial evaluation of bronchoalveolar lavage cells during corticosteroid treatment. Pediatr Pulmonol 16: 41–47PubMedCrossRefGoogle Scholar
  14. Hafner R, Vogel P (1993) Sarcoidosis of early onset. A challenge for the pediatric rheumatologist. Clin Exp Rheumatol 11: 685–691Google Scholar
  15. Heyll A, Meckenstock G, Aul C et al. (1994) Possible transmission of sarcoidosis via allogenic bone marrow transplantation. Bone Marrow Transplant 14: 161–164PubMedGoogle Scholar
  16. Marcille R, McCarthy M, Barton JW, Merten DF, Spock A (1992) Long-term outcome of pediatric sarcoidosis with emphasis on pulmonary status. Chest 102: 1444–1449PubMedCrossRefGoogle Scholar
  17. Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336: 1224–1234CrossRefGoogle Scholar
  18. Oni AA, Hershberger RE, Norman DJ et al. (1992) Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 11: 367–369PubMedGoogle Scholar
  19. Pattishall EN, Kendig EL (1996) Sarcoidosis in children. Pediatr Pulmonol 22: 195–203PubMedCrossRefGoogle Scholar
  20. Richter E, Greinert U, Kirsten D et al. (1996) Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. Am J Respir Crit Care Med 153: 375PubMedCrossRefGoogle Scholar
  21. Arceci RI, Brenner MK, Pritchard J (1998) Controversies and new approaches on treatment of Langerhans cell histiocytosis. Hematol Oncol North Am 12: 339–357CrossRefGoogle Scholar
  22. Broadbent V, Gadner H, Komp DM, Ladisch S (1989) Histiocytosis syndromes in children II: Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Med Pediatr Oncol 17: 492–495Google Scholar
  23. Broadbent V, Gadner H (1998) Current therapy for Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12: 327–338PubMedCrossRefGoogle Scholar
  24. Egeler RM, Nesbit ME (1995) Langerhans cell histiocytosis and other disorders of monocyte-histiocyte lineage. Crit Rev Oncol Hematol 18: 9–35PubMedCrossRefGoogle Scholar
  25. Favara BE, Feller AC, Pauli M et al. (1997) Contemporary classification of histiocyte disorders. Med Pediatr Oncol 29: 157–166PubMedCrossRefGoogle Scholar
  26. Féfabert L, Rambaud C, Mamou-Mani T, Scheinmann P, de Blic J (1996) CD 1 a-positive cells in bronchoalveolar lavage samples from children with Langerhans cell histiocytosis. J Pediatr 129: 913–915CrossRefGoogle Scholar
  27. French Langerhans’ Cell Histiocytosis Study Group (1996) A multicentre retrospective survey of Langerhans’ cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 75: 17–24CrossRefGoogle Scholar
  28. Ha SY, Helms P, Fletcher M, Boadbent V, Pritchard J (1992) Lung involvement in Langerhans’ cell histiocytosis: prevalence, clinical features, and outcome. Pediatrics 89: 466–469PubMedGoogle Scholar
  29. Liebermann PH, Jones CR, Steinmann RM et al. (1996) Langerhans cell (eosinophilic) granulomatosis. A clinicopathological study encompassing 50 years. Am J Surg Pathol 20: 519–552CrossRefGoogle Scholar
  30. McDowell HP, MacFarlane PI, Martin J (1988) Isolated pul- monary histiocytosis. Arch Dis Child 63: 423–426PubMedCrossRefGoogle Scholar
  31. Soler P, Tazi A, Hance AJ (1995) Pulmonary Langerhans cell granulomatosis. Curr Opin Pulm Med 1: 406–416PubMedGoogle Scholar
  32. Travis WD, Borok Z, Roum JH, Fenerstein I, Ferrans VJ, Crystal RG (1993) Pulmonary Langerhans’ cell histiocytosis (histiocytosis X): a clinicopathological study in 48 cases. Am J Surg Pathol 17: 971–986PubMedCrossRefGoogle Scholar
  33. Willis B, Ablin A, Weinberg V, Zoger S, Wara WM, Matthay KK (1996) Disease course and late sequels of Langerhans’ cell histiocytosis: a 25-year experience at the University of California, San Francisco. J Clin Oncol 14: 2073–2082Google Scholar
  34. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gillian DG (1994) Langerhans’ cell histiocytosis (histiocytosis X)–a clonal proliferative disease. N Engl J Med 331: 154–160PubMedCrossRefGoogle Scholar
  35. Bollinger BK, Laskin WB, Knigt CB (1994) Epithelioid hemangioendothelioma with multiple site involvement. Literature review and observations. Cancer 73: 610–615Google Scholar
  36. Corrin B, Dewar A, Simpson CG (1996) Epithelioid hemangioendothelioma of the lung. Ultrastruct Pathol 20: 345–347PubMedCrossRefGoogle Scholar
  37. Dail DH (1994) Epithelioid hemangioendothelioma. In: Dail DH, Hammar SP (eds) Pulmonary pathology, 2nd edn. Springer, Berlin Heidelberg New York Tokyo, pp 1406–1414CrossRefGoogle Scholar
  38. Dail DH, Liebow AA, Gmelich J et al. (1983) Intravascular, bronchiolar, and alveolar tumor of the lung (IVBAT). Cancer 51: 452–464PubMedCrossRefGoogle Scholar
  39. Kitaichi M, Nagai S, Nishimura K, Itoh H, Asamoto H, Izumi T, Dail DH (1998) Pulmonary epithelioid hemangioendothelioma in 21 patients including three with partial spontaneous remission. Eur Respir J 12: 89–96PubMedCrossRefGoogle Scholar
  40. Luburich P, Ayuso MC, Picado C, Serra-Batlés, Ramirez JF, Solé M (1994) CT of pulmonary epithelioid hemangioendothelioma. J Comput Assist Tomogr 18: 562–565PubMedCrossRefGoogle Scholar
  41. Ohori NP, Yousem SA, Sonmez-Alpan E, Colby TV (1991) Estrogen and progesterone receptors in lymphangioleiomyomatosis, epithelioid hemangioendothelioma and sclerosing hemangioma of the lung. Am J Clin Pathol 96: 529–535PubMedGoogle Scholar
  42. Rock MJ, Kaufman RA, Lobe TE, Hensley SD, Moss ML (1991) Epithelioid hemangioendothelioma of the lung (intravascular bronchioalveolar tumor) in a young girl. Pediatr Pulmonol 11: 181–186PubMedCrossRefGoogle Scholar
  43. Shiraksu T, Yoshida M, Tsustui M (1989) Advanced intra-vascular bronchoalveolar tumor and review of reports in Japan. Respir Med 85: 127–132CrossRefGoogle Scholar
  44. Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM (1986) Epithelioid hemangioendothelioma and related lesions. Semin Diagn Pathol 3: 259–287PubMedGoogle Scholar
  45. Bass HN, LaGrave D, Mardach R, Cederbaum SD, Fuster CD, Chetty MJ (1997) Spontaneous pneumothorax in association with pyridoxine-responsive homocystinuria. Inherit Metab Dis 20: 831CrossRefGoogle Scholar
  46. Bush A, Du Bois R (1996) Congenital and pediatric interstitial disease. Curr Opin Pulm Med 2: 347PubMedCrossRefGoogle Scholar
  47. Kerem E, Elstein D, Abrahamov A et al. (1996) Pulmonary function abnormalities in type I Gaucher disease. Eur Respir J 9: 340PubMedCrossRefGoogle Scholar
  48. Lieberman J (1988) Inherited diseases of the lung. Saunders, PhiladelphiaGoogle Scholar
  49. Matsumoto T, Matsumori H, Taki T, Takagi T, Fukuda Y (1979) Infantile GM,-gangliosidosis with marked manifestation of lungs. Acta Pathol Jpn 29: 269PubMedGoogle Scholar
  50. Noggemana B, Rebien W, Rahn W, Wahn U (1994) Asymptomatic involvement in 2 children with Niemann-Pick disease type B. Respiration 61: 55CrossRefGoogle Scholar
  51. Nyhan WL, Ozand PT (1998) Atlas of metabolic diseases. Chapman & Hall MedicalGoogle Scholar
  52. Schofer O, Mischo B, Puschel W, Harzer K, Vanier MT (1998) Early lethal pulmonary form of Niemann-Pick Typ C disease belonging to a second, rare genetic complementation group. Eur J Pediatr 157: 45PubMedCrossRefGoogle Scholar
  53. Smets A, Mortele K, de Praeter G, Francois 0, Benoit Y, Kunnen M (1997) Pulmonary and mediastinal lesions in children with Langerhans cell histiocytosis. Pediatr Radiol 27: 873PubMedCrossRefGoogle Scholar
  54. Soler P, Tazi A, Hance AJ (1995) Pulmonary Langerhans cell granulomatosis. Curr Opin Pulm Med 1: 406PubMedGoogle Scholar
  55. Fisher M, Roggli V, Merten D, Mulvihill D, Spock A (1992) Coexisting endogenous lipoid pneumonia, cholesterol granulomas, and pulmonary alveolar proteinosis in a pedriatric population: a clinical radiographic and pathologic correlation. Pediatr Pathol 12: 365–383PubMedCrossRefGoogle Scholar
  56. Hugosson CO, Riff EJ, Moore CCM, Akhtar M, Tufenkeji HT (1991) Lipoid pneumonia in infants: a radiographical pathological study. Pediatr Radiol 21: 193–197PubMedCrossRefGoogle Scholar
  57. Sato K, Takahashi H, Amano H (1996) Diffuse progressive pulmonary interstitial and intraalveolar cholesterol granulomas in childhood. Eur Respir J 9: 2419–2422PubMedCrossRefGoogle Scholar
  58. Spickard A, Hirschmann JV (1994) Exogenous lipoid pneumonia. Arch Intern Med 154: 686–692PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • E. Weissbarth-Riedel
  • C. Rieger
  • K. Paul
  • N. Teig
  • H. von der Hardt
  • V. Stephan

There are no affiliations available

Personalised recommendations